Trastuzumab is the first of the monoclonal antibodies to be used in the treatment of those patients who have HER2-positive metastatic breast cancer. It is most effective when combined with ...

Cite this: Trastuzumab as the Lead Monoclonal Antibody in Advanced Breast Cancer: Choosing Which Patient and When - Medscape - Feb 01, 2008. Disclosure: The author has no relevant affiliations or ...

The traditional method of generating antibodies by immunizing animals struggles to make antibodies related to these protein complexes. The conventional method is prone to failure because protein ...

The body's immune system mistakenly produces "autoantibodies," or antibodies that attack its own tissues and proteins. In the case of myasthenia gravis, the body produces autoantibodies that ...

Herceptin SC belongs to a class of anti-neoplastic agents called monoclonal antibodies ... or miss your appointment to receive Herceptin SC, make another appointment as soon as possible.

The traditional method of generating antibodies by immunizing animals struggles to make antibodies related to these protein complexes. The conventional method is prone to failure because protein ...

A new cancer drug called trastuzumab deruxtecan, also known as Enhertu, has just been approved in the UK. This drug is designed to help adults with certain types of advanced cancer that cannot be ...

Absci has also been working with Caltech on a universally neutralizing HIV antibody, which the company believes is illustrative of its ability to design antibodies that target previously ...

Pharma distributor AmerisourceBergen is working on a platform to make access to digital therapeutics (DTx) easier in the US by providing a unified system for ordering, dispensing and fulfilment.

to $1.42 near the close of trading after the Food and Drug Administration announced that it is replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...